Logo image of XCH

XCHG LTD (XCH) Stock Fundamental Analysis

NASDAQ:XCH - Nasdaq - US98370X1037 - ADR - Currency: USD

1.44  -0.02 (-1.37%)

Fundamental Rating

2

XCH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 94 industry peers in the Electrical Equipment industry. Both the profitability and financial health of XCH have multiple concerns. XCH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

XCH had negative earnings in the past year.
XCH had a negative operating cash flow in the past year.
XCH Yearly Net Income VS EBIT VS OCF VS FCFXCH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

XCH has a Return On Assets (-22.93%) which is comparable to the rest of the industry.
The Return On Equity of XCH (-44.40%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -22.93%
ROE -44.4%
ROIC N/A
ROA(3y)-16.13%
ROA(5y)N/A
ROE(3y)-49.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XCH Yearly ROA, ROE, ROICXCH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

XCH has a Gross Margin of 50.29%. This is amongst the best in the industry. XCH outperforms 96.81% of its industry peers.
XCH's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for XCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.46%
GM growth 5YN/A
XCH Yearly Profit, Operating, Gross MarginsXCH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

XCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
XCH has more shares outstanding than it did 1 year ago.
The debt/assets ratio for XCH has been reduced compared to a year ago.
XCH Yearly Shares OutstandingXCH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
XCH Yearly Total Debt VS Total AssetsXCH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that XCH is in the distress zone and has some risk of bankruptcy.
XCH's Altman-Z score of 1.24 is in line compared to the rest of the industry. XCH outperforms 54.26% of its industry peers.
XCH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, XCH is in line with its industry, outperforming 53.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC6.44%
XCH Yearly LT Debt VS Equity VS FCFXCH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 2.08 indicates that XCH has no problem at all paying its short term obligations.
The Current ratio of XCH (2.08) is comparable to the rest of the industry.
A Quick Ratio of 1.78 indicates that XCH should not have too much problems paying its short term obligations.
The Quick ratio of XCH (1.78) is better than 68.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.78
XCH Yearly Current Assets VS Current LiabilitesXCH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

XCH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.82%.
XCH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.59%.
The Revenue has been growing by 47.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-131.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1033.33%
Revenue 1Y (TTM)9.59%
Revenue growth 3Y47.48%
Revenue growth 5YN/A
Sales Q2Q%301.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XCH Yearly Revenue VS EstimatesXCH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XCH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XCH Price Earnings VS Forward Price EarningsXCH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XCH Per share dataXCH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XCH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XCHG LTD

NASDAQ:XCH (6/23/2025, 8:00:02 PM)

1.44

-0.02 (-1.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)04-23 2025-04-23
Earnings (Next)N/A N/A
Inst Owners0.47%
Inst Owner Change87.4%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap85.61M
AnalystsN/A
Price TargetN/A
Short Float %0.22%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 2.9
P/tB 2.9
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.71
BVpS0.5
TBVpS0.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.93%
ROE -44.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.29%
FCFM N/A
ROA(3y)-16.13%
ROA(5y)N/A
ROE(3y)-49.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.46%
GM growth 5YN/A
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 263.5%
Cap/Sales 1.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 1.78
Altman-Z 1.24
F-Score5
WACC6.44%
ROIC/WACCN/A
Cap/Depr(3y)225.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1033.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.59%
Revenue growth 3Y47.48%
Revenue growth 5YN/A
Sales Q2Q%301.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.17%
OCF growth 3YN/A
OCF growth 5YN/A